Abstract:Nucleic acid-based therapy has emerged as a revolutionary methodology for treatment of the diseases related to protein dysfunction; however, lack of systemically applicable synthetic delivery systems limits its current usage in local applications, particularly for DNA-based therapy with regard to the poor bioavailability in the systemic administrations. To overcome this obstacle, we compiled multiple chemistry-based strategies into the manufacture of the gene delivery formulations to pursue improved tolerability of DNA to the enzymatic degradation in the biological milieu and prolonged retention in the systemic circulation. Here, we constructed a distinctive multilayered functional architecture: plasmid DNA (pDNA) was electrostatically complexed with cationic poly(lysine) (polyplex) as the interior pDNA reservoir, which was further cross-linked by redox-responsive disulfide cross-linking to minimize the occurrence of polyplex disassembly through exchange reaction with the biological charged,components. Still, the pDNA reservoir was spatially protected by a sequential thermoresponsive poly(N-isopropylacrylamide) palisade as the intermediate barrier and a biocompatible hydrophilic poly(ethylene glycol) (PEG) shell with the aim of preventing the accessibility of the biological species, particularly the nuclease degradation to the pDNA payload. Subsequent investigations validated the utilities of these strategies in accomplishing prolonged blood retention. In an attempt to apply this method for tumor therapy, ligand cyclic (Arg-Gly-Asp) peptide was attached at the distal end of PEG, validating prompted tumor-targeted delivery and gene expression of the loaded antiangiogenic gene at the targeted tumor cells and accordingly exerting antiangiogenesis of the tumors for abrogation of tumor growth. Together with its excellent safe profile, the proposed formulation suggests potential utility as a practical gene delivery system for treatment of intractable diseases.

Multifunctional nucleic acid nanostructures for gene therapies

Nucleic acid nanostructure for delivery of CRISPR/Cas9‐based gene editing system

Polymeric Nanostructure Compiled with Multifunctional Components to Exert Tumor-Targeted Delivery of Antiangiogenic Gene for Tumor Growth Suppression

DNA-based nanostructures for RNA delivery

Nucleic acid nanoassembly-enhanced RNA therapeutics and diagnosis

Zwitterionic Materials for Nucleic Acid Delivery and Therapeutic Applications

DNA Nanostructure‐Based Systems for Intelligent Delivery of Therapeutic Oligonucleotides

Therapeutic applications of RNA nanostructures

Recent advances in DNA nanostructure‐enabled drug delivery

Programmable Assembly of Multivalent DNA‐Protein Superstructures for Tumor Imaging and Targeted Therapy

Nanobiomaterial Vectors for Improving Gene Editing and Gene Therapy

RNA nanostructures for targeted drug delivery and imaging

Carbon-Based Nanostructures as Emerging Materials for Gene Delivery Applications

Recent Advance of Liposome Nanoparticles for Nucleic Acid Therapy

CRISPR/Cas systems combined with DNA nanostructures for biomedical applications

Construction of nanocarriers based on nucleic acids and their application in nanobiology delivery systems

DNA Nanotechnology-Enabled Drug Delivery Systems.

Nucleic acid drug and delivery techniques for disease therapy: present situation and future prospect (1/2024)

Combinational Application of Metal–organic Frameworks‐based Nanozyme and Nucleic Acid Delivery in Cancer Therapy

DNA nanomaterials for preclinical imaging and drug delivery

Therapeutic Applications of Programmable DNA Nanostructures